📄 Kentucky
Sign in

Back to


Kentucky


Biologics Compliance Guide for Clinics in Kentucky

Learn the essential compliance steps to confidently offer biologics in Kentucky. This guide covers state and FDA regulations, patient consent, and best practices to help you establish compliant stem cell therapy services.


1. Summary

Clinics in Kentucky looking to offer biologics, such as stem cell therapies, must adhere to both federal and state regulations. This guide provides an overview of key compliance requirements for clinics and practitioners, helping you navigate essential legal and procedural guidelines confidently.


2. FDA Compliance

The U.S. Food and Drug Administration (FDA) regulates human cells, tissues, and cellular and tissue-based products (HCT/Ps). Kentucky providers offering biologics must comply with these federal standards to ensure that therapies are administered safely and ethically.

FDA’s 21 CFR Part 1271

FDA’s 21 CFR Part 1271 outlines requirements for HCT/P products, covering criteria such as donor eligibility, manufacturing practices, and labeling. Providers are advised to review these standards and confirm that treatments offered are either exempt or fall within the FDA’s guidelines for approved biologics.


3. Kentucky State Regulations

Kentucky has specific requirements regarding biologics administration. Clinics and practitioners must comply with the Kentucky Cabinet for Health and Family Services. For state-specific regulations, visit the Kentucky Department for Public Health website.


4. Provider Qualifications

In Kentucky, licensed medical professionals such as MDs and DOs with appropriate qualifications are eligible to administer biologics. Providers must also comply with state-specific licensing requirements, including Kentucky Board of Medical Licensure regulations for physicians.


5. Patient Informed Consent

To ensure transparency, providers should present a clear informed consent form that addresses:

  • The experimental nature of some stem cell therapies
  • Potential benefits and risks associated with treatment
  • Alternative treatment options
  • A statement that FDA approval may not cover all biologic therapies


6. Additional Compliance Considerations
Pre-Treatment and Post-Treatment Protocols

Implement detailed protocols to standardize patient assessments and post-treatment monitoring. These protocols improve patient safety and ensure compliance with regulatory expectations.

Standard Operating Procedures (SOPs)

Develop SOPs covering patient eligibility, treatment administration, and infection control to meet state and federal safety standards.

Medical Liability Insurance

Secure a comprehensive insurance policy that covers biologic treatments, ensuring adequate liability protection for the clinic and staff.

Marketing Compliance

Advertise responsibly by avoiding unverified claims and adhering to both FDA and FTC guidelines. Include disclaimers when promoting stem cell therapies, emphasizing any limitations in research support or FDA approval.

This guide is provided as an informational resource to help clinics and practitioners understand general compliance requirements for biologics in Kentucky. It is not intended to serve as legal advice or replace consultation with qualified legal professionals. Regulations may vary and are subject to change; clinics and practitioners should consult legal counsel or regulatory experts for advice specific to their circumstances and ensure full compliance with all applicable federal and state laws. The authors and publishers of this guide disclaim any liability arising from its use or reliance on the information provided.